Pfizer 2025 earnings. That's the good news. The bad news is that while Pfizer "beat" on both sales and adjusted earnings, its ...
We came across a bullish thesis on Pfizer Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will ...
Global pharmaceutical company Pfizer (NYSE:PFE) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 1.2% ...
Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results